These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9551875

  • 1. Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertension.
    Stumpe KO, Haworth D, Hoglund C, Kerwin L, Martin A, Simon T, Masson C, Kassler-Taub K, Osbakken M.
    Blood Press; 1998 Jan; 7(1):31-7. PubMed ID: 9551875
    [Abstract] [Full Text] [Related]

  • 2. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
    Oparil S, Guthrie R, Lewin AJ, Marbury T, Reilly K, Triscari J, Witcher JA.
    Clin Ther; 1998 Jan; 20(3):398-409. PubMed ID: 9663357
    [Abstract] [Full Text] [Related]

  • 3. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
    Rosenstock J, Rossi L, Lin CS, MacNeil D, Osbakken M.
    J Clin Pharm Ther; 1998 Dec; 23(6):433-40. PubMed ID: 10048504
    [Abstract] [Full Text] [Related]

  • 4. A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension.
    Mimran A, Ruilope L, Kerwin L, Nys M, Owens D, Kassler-Taub K, Osbakken M.
    J Hum Hypertens; 1998 Mar; 12(3):203-8. PubMed ID: 9579771
    [Abstract] [Full Text] [Related]

  • 5. Regression of left ventricular hypertrophy in human hypertension with irbesartan.
    Malmqvist K, Kahan T, Edner M, Held C, Hägg A, Lind L, Müller-Brunotte R, Nyström F, Ohman KP, Osbakken MD, Ostergern J.
    J Hypertens; 2001 Jun; 19(6):1167-76. PubMed ID: 11403367
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.
    Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E.
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):445-53. PubMed ID: 9607383
    [Abstract] [Full Text] [Related]

  • 7. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
    Mörtsell D, Malmqvist K, Held C, Kahan T.
    J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
    [Abstract] [Full Text] [Related]

  • 8. The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group.
    Howe P, Phillips P, Saini R, Kassler-Taub K.
    Clin Exp Hypertens; 1999 Nov; 21(8):1373-96. PubMed ID: 10574419
    [Abstract] [Full Text] [Related]

  • 9. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.
    Kochar M, Guthrie R, Triscari J, Kassler-Taub K, Reeves RA.
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):797-805. PubMed ID: 10480473
    [Abstract] [Full Text] [Related]

  • 10. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A, Calvo C, García-Puig J, Gil-Extremera B, Aguilera MT, de la Sierra A, Martín-Hidalgo A, Marín R, MAPAVEL Investigators (Monitorizacíon Ambulatoria Presión Arterial APROVEL).
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [Abstract] [Full Text] [Related]

  • 11. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
    Chiou KR, Chen CH, Ding PY, Chen YT, Ting CT, Huang JL, Chiang AH, Liu CP, Tseng CJ, Chao CT, Chang MS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):368-76. PubMed ID: 10862446
    [Abstract] [Full Text] [Related]

  • 12. Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.
    Pool JL, Guthrie RM, Littlejohn TW, Raskin P, Shephard AM, Weber MA, Weir MR, Wilson TW, Wright J, Kassler-Taub KB, Reeves RA.
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):462-70. PubMed ID: 9607385
    [Abstract] [Full Text] [Related]

  • 13. Treatment with irbesartan or atenolol improves endothelial function in essential hypertension.
    von zur Mühlen B, Kahan T, Hägg A, Millgård J, Lind L.
    J Hypertens; 2001 Oct; 19(10):1813-8. PubMed ID: 11593101
    [Abstract] [Full Text] [Related]

  • 14. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
    Raskin P, Guthrie R, Flack J, Reeves R, Saini R.
    J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
    [Abstract] [Full Text] [Related]

  • 15. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL, Park JB, Pu Q.
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
    Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nyström F, Hägg A, Lind L, Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial.
    J Hypertens; 2001 Oct; 19(10):1783-7. PubMed ID: 11593098
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension.
    Lacourcière Y.
    Clin Ther; 2000 Oct; 22(10):1213-24. PubMed ID: 11110232
    [Abstract] [Full Text] [Related]

  • 18. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R, Kahan T, Malmqvist K, Ring M, Edner M.
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [Abstract] [Full Text] [Related]

  • 19. Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
    Neutel JM, Germino FW, Smith D.
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):84-9. PubMed ID: 16470487
    [Abstract] [Full Text] [Related]

  • 20. Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension.
    Neutel JM, Franklin SS, Bhaumik A, Lapuerta P, Oparil S.
    Clin Exp Hypertens; 2009 Oct; 31(7):572-84. PubMed ID: 19886855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.